ProCE Banner Activity

Suboptimal Clinician Awareness of Appropriate NTRK Fusion Testing and TRK Inhibitor Use in Solid Tumors


This poster, presented at the 2021 ASCO Quality Care Symposium, features an analysis of data from 12 CME-certified programs and demonstrates an ongoing need for healthcare professional education focused on NTRK fusion testing and optimal use of TRK inhibitor therapies in patients with solid tumors.

Released: September 23, 2021

Expiration: September 22, 2022


Additional Information

Ryan P. Topping, PhD
Senior Scientific Director
Clinical Care Options
Telephone: 855.224.2241